At baseline, 95% of patients were treated with an ACE inhibitor or ARB, 16% were on sodium-glucose cotransporter 2 (SGLT2) inhibitors, 76% were on a statin, and 50% were on an antiplatelet agent
0.25 mg of semaglutide is 25 units on a U-100 insulin syringe if your concentration is 1 mg/mL, or 10 units if your concentration is 2.5 mg/mL
Weight trajectories stabilized after 12 months, with only small variations in the distribution of weight outcomes through year two
Pairing semaglutide and IFa strategy restricting your eating to a specific time windowmight accelerate fat loss by creating a caloric deficit
GH stimulation may theoretically encourage tumor growth, so this therapy is avoided in anyone with an active malignancy or a history of cancer that is not in complete remission
A single miscalculation in bacteriostatic water volume can reduce your effective semaglutide concentration by 30 to 40 percent, turning what should be a precise weekly dose into a guessing game that undermines your entire protocol